These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 17512814)
21. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. Tsurukai T; Udagawa N; Matsuzaki K; Takahashi N; Suda T J Bone Miner Metab; 2000; 18(4):177-84. PubMed ID: 10874596 [TBL] [Abstract][Full Text] [Related]
22. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis. Park H; Jung YK; Park OJ; Lee YJ; Choi JY; Choi Y J Immunol; 2005 Dec; 175(11):7193-201. PubMed ID: 16301623 [TBL] [Abstract][Full Text] [Related]
23. DICAM inhibits osteoclast differentiation through attenuation of the integrin αVβ3 pathway. Jung YK; Han SW; Kim GW; Jeong JH; Kim HJ; Choi JY J Bone Miner Res; 2012 Sep; 27(9):2024-34. PubMed ID: 22492581 [TBL] [Abstract][Full Text] [Related]
24. Characterization of terminal sialic acid linkages on human thymocytes. Correlation between lectin-binding phenotype and sialyltransferase expression. Baum LG; Derbin K; Perillo NL; Wu T; Pang M; Uittenbogaart C J Biol Chem; 1996 May; 271(18):10793-9. PubMed ID: 8631891 [TBL] [Abstract][Full Text] [Related]
25. Enterovirus 70 binds to different glycoconjugates containing alpha2,3-linked sialic acid on different cell lines. Nokhbeh MR; Hazra S; Alexander DA; Khan A; McAllister M; Suuronen EJ; Griffith M; Dimock K J Virol; 2005 Jun; 79(11):7087-94. PubMed ID: 15890948 [TBL] [Abstract][Full Text] [Related]
26. Regulators of osteoclast differentiation and cell-cell fusion. Miyamoto T Keio J Med; 2011; 60(4):101-5. PubMed ID: 22200633 [TBL] [Abstract][Full Text] [Related]
27. α2-3 Sialic acid glycoconjugate loss and its effect on infection with Toxoplasma parasites. Nishikawa Y; Ogiso A; Kameyama K; Nishimura M; Xuan X; Ikehara Y Exp Parasitol; 2013 Nov; 135(3):479-85. PubMed ID: 23988663 [TBL] [Abstract][Full Text] [Related]
28. Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells. Xu XY; Guo C; Yan YX; Guo Y; Li RX; Song M; Zhang XZ Mol Med Rep; 2012 Aug; 6(2):409-15. PubMed ID: 22580758 [TBL] [Abstract][Full Text] [Related]
29. PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Hikata T; Takaishi H; Takito J; Hakozaki A; Furukawa M; Uchikawa S; Kimura T; Okada Y; Matsumoto M; Yoshimura A; Nishimura R; Reddy SV; Asahara H; Toyama Y Blood; 2009 Mar; 113(10):2202-12. PubMed ID: 18952894 [TBL] [Abstract][Full Text] [Related]
30. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells. Egusa H; Doi M; Saeki M; Fukuyasu S; Akashi Y; Yokota Y; Yatani H; Kamisaki Y Bone; 2011 Aug; 49(2):264-74. PubMed ID: 21504804 [TBL] [Abstract][Full Text] [Related]
32. CD109 plays a role in osteoclastogenesis. Wang Y; Inger M; Jiang H; Tenenbaum H; Glogauer M PLoS One; 2013; 8(4):e61213. PubMed ID: 23593435 [TBL] [Abstract][Full Text] [Related]
33. Differentiation -dependent expression of human beta-galactoside alpha 2,6-sialyltransferase mRNA in colon carcinoma CaCo-2 cells. Dall'Olio F; Malagolini N; Guerrini S; Lau JT; Serafini-Cessi F Glycoconj J; 1996 Feb; 13(1):115-21. PubMed ID: 8785482 [TBL] [Abstract][Full Text] [Related]
34. Cystathionine γ-lyase accelerates osteoclast differentiation: identification of a novel regulator of osteoclastogenesis by proteomic analysis. Itou T; Maldonado N; Yamada I; Goettsch C; Matsumoto J; Aikawa M; Singh S; Aikawa E Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):626-34. PubMed ID: 24357058 [TBL] [Abstract][Full Text] [Related]
35. Recognition of cell surface acceptors by two human alpha-2,6-sialyltransferases produced in CHO cells. Donadio S; Dubois C; Fichant G; Roybon L; Guillemot JC; Breton C; Ronin C Biochimie; 2003; 85(3-4):311-21. PubMed ID: 12770770 [TBL] [Abstract][Full Text] [Related]
36. Differentiation elicits negative regulation of human beta-galactoside alpha2,6-sialyltransferase at the mRNA level in the HL-60 cell line. Taniguchi A; Higai K; Hasegawa Y; Utsumi K; Matsumoto K FEBS Lett; 1998 Dec; 441(2):191-4. PubMed ID: 9883882 [TBL] [Abstract][Full Text] [Related]
37. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis. Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243 [TBL] [Abstract][Full Text] [Related]
38. CpG oligonucleotides: novel regulators of osteoclast differentiation. Zou W; Schwartz H; Endres S; Hartmann G; Bar-Shavit Z FASEB J; 2002 Mar; 16(3):274-82. PubMed ID: 11874977 [TBL] [Abstract][Full Text] [Related]
39. The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5. Crockett JC; Schütze N; Tosh D; Jatzke S; Duthie A; Jakob F; Rogers MJ Endocrinology; 2007 Dec; 148(12):5761-8. PubMed ID: 17823253 [TBL] [Abstract][Full Text] [Related]
40. Modification of cell surfaces by enzymatic introduction of special sialic acid analogues. Kosa RE; Brossmer R; Gross HJ Biochem Biophys Res Commun; 1993 Feb; 190(3):914-20. PubMed ID: 8439340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]